secwatch.observer — SEC 8-K summary
======================================

Issuer:     BAXTER INTERNATIONAL INC (BAX)
CIK:        0000010456
Form:       8-K
Filed at:   2026-02-12T23:59:59+00:00
Accession:  0001628280-26-007474
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 8.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baxter Q4 GAAP EPS loss ($2.01), adj. $0.44; sales $2.97B +8%; div cut to $0.01
-------------------------------------------------------------------------------

- Q4 sales $2.97B (+8% reported, +3% operational); GAAP diluted EPS loss ($2.01), adjusted diluted EPS $0.44.
- Board appoints Michael R. McDonnell (former Biogen CFO); directors Cathy Smith and Stephen Rusckowski resign effective Feb 13.
- Quarterly dividend declared at $0.01 per share, payable April 1, 2026 to holders of record Feb 27, 2026.
- CEO Hider: Q4 results missed expectations; new operating model aims to simplify organization and accelerate innovation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10456/000162828026007474/0001628280-26-007474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10456/000162828026007474/bax-20260210.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-007474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer